A New Kind of
Biologics Engine
Animerra’s platform is purpose-built for companion animal health. By pairing a novel screening and discovery engine with next-generation protein modalities that go beyond conventional antibody formats, we can efficiently pursue harder targets — ion channels, GPCRs, cryptic epitopes — and design drug candidates with the attributes that matter in veterinary medicine: efficacy, safety, and convenient dosing.
Animerra’s platform is uniquely positioned to harness the power of AI. Our ultra-high-diversity mRNA display libraries generate the rich sequence depth and binding data that AI models need to identify patterns human analysis would miss. We are actively integrating AI tools — from protein structure prediction to sequence-based clustering and epitope analysis — to deepen our understanding of each screen, design better libraries, accelerate hit identification, and improve the quality of those identified hits. The result is a discovery engine that becomes more powerful with every campaign.
Addressing the
Unmet Needs That Matter
Animerra is focused on three therapeutic areas where the limitations of traditional biologics have left significant gaps in companion animal care: chronic pain, fibrosis-driven diseases, and allergic diseases. In each area, we are pursuing targets uniquely accessible to our platform — with the potential to deliver meaningfully better outcomes for cats, dogs, and the people who love them.
